t-cells

Documents about t-cells

• Depletion of extracellular asparagine impairs self-reactive T cells and ameliorates autoimmunity in a murine model of multiple sclerosis#485067Europe PMC
• BCL6 in T cells promotes type 1 diabetes by redirecting fates of insulin-autoreactive B lymphocytes#485224Europe PMC
• Protocol to evaluate cell lineage stability of mouse natural and induced regulatory T cells using bisulfite sequencing#625615Kyoto University Research Information Repository
• Protocol to evaluate cell lineage stability of mouse natural and induced regulatory T cells using bisulfite sequencing#625638Kyoto University Research Information Repository
• Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody#849116ClinicalTrials.gov
• Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)#851961ClinicalTrials.gov
• Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients#916216ClinicalTrials.gov
• Investigating the immunomodulatory properties of Nippostrongylus brasiliensis; a potential model for Necator americanus#990192University of Nottingham Repository
• A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia#995508ClinicalTrials.gov
• Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)#1048015ClinicalTrials.gov
• Mechanisms and therapeutic strategies of bidirectional crosstalk between hepatic stellate cell-derived cancer-associated fibroblasts and T cells in immune evasion and therapeutic resistance of hepatocellular carcinoma.#1054105NCBI PubMed Central
• Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL#881288ClinicalTrials.gov
• Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia#968677ClinicalTrials.gov
• Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab#968753ClinicalTrials.gov
• Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1#146267ClinicalTrials.gov
• Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children#217185ClinicalTrials.gov
• Stochastic analysis of tumor microenvironment dynamics: Interplay between cytotoxic T-cells and cancer-associated fibroblasts#250325HAL (France)
• PD-1 and TIGIT coexpression enables selective enrichment of clonally expanded tumor-reactive CD8 T cells for melanoma TIL therapy#347883HAL (France)
• Therapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026#353872Europe PMC
• Decreased CD3+CD56+ Natural Killer T Lymphocytes and Increased Human Leukocyte Antigen-DR+ Cells in the Inflamed Area of Pouchitis in Ulcerative Colitis Patients#455581OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• CMV-CMI in csCMVi After HSCT#861273ClinicalTrials.gov
• Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma#869555ClinicalTrials.gov
• Clinical Trial to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Multiple Myeloma#883306ClinicalTrials.gov
• Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia#901637ClinicalTrials.gov
• Activating mutations of STAT5B and STAT3 in lymphomas derived from ??-T or NK cells.#954783Koc University Digital Collections
• DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer#979623ClinicalTrials.gov
• HIV-1 - HOST-CENTRIC SEQUESTRATION PARADIGM SCIENTIFIC VALIDATION & HIV CURE PATH. AN ADVANCED LOGICAL SYNTHESIS & EMPIRICAL VALIDATION OF HIV-1 LATENCY AS ACTIVE CELLULAR SELF-PRESERVATION - QUIESCENCE CD4+ T CELLS#990605Zenodo (CERN)
• 3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN#1045689ClinicalTrials.gov
• Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies#837867ClinicalTrials.gov
• Long-term Follow-up Study of Patients Receiving CAR-T Cells#918878ClinicalTrials.gov
• Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer#125828ClinicalTrials.gov
• Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies#136335ClinicalTrials.gov
• Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells#181761ClinicalTrials.gov
• The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies#287558ClinicalTrials.gov
• CD4 expression decrease by antisense oligonucleotides. Inhibition of rat T CD4+ cell reactivity#433041Dipòsit Digital de la Universitat de Barcelona
• Targeted delivery of mRNA to immune cells for <i>in vivo</i> cell therapy#676323Europe PMC
• Transcriptional and functional profiling reveals unique activation of Adapter CAR T cells in acute myeloid leukemia / Nele Knelangen, Ulrika Bader, Evangelia Maniaki, Boris Engels, Luca Gattinoni, Jörg Mittelstät#784006Deutsche Nationalbibliothek
• GPC3/Mesothelin-CAR-γδT Cells Against Cancers#879860ClinicalTrials.gov
• Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas#885787ClinicalTrials.gov
• Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma#888742ClinicalTrials.gov
• Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies#893013ClinicalTrials.gov
• CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children#911818ClinicalTrials.gov
• A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma#1044341ClinicalTrials.gov
• The prognostic impact of monocyte fluorescence, immunosuppressive monocytes and peripheral blood immune cell numbers in HIV-associated Diffuse Large B-cell Lymphoma#279057WIReDSpace
• Lack of immunogenicity for an influenza-derived peptide across the HLA-B44 supertype molecules#448603Figshare
• A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer#801446ClinicalTrials.gov
• Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections#849277ClinicalTrials.gov
• Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children#879150ClinicalTrials.gov
• Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis#901469ClinicalTrials.gov
• Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery.#994077ClinicalTrials.gov